866-997-4948(US-Canada Toll Free)

Global Follow-on Biologics Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Oct 2018

Category :

Pharmaceutical

No. of Pages : 113 Pages

In 2017, the global Follow-on Biologics market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Follow-on Biologics market based on company, product type, application and key regions.

This report studies the global market size of Follow-on Biologics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Follow-on Biologics in these regions.
This research report categorizes the global Follow-on Biologics market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Follow-on Biologics include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Follow-on Biologics include
Sandoz
Pfizer
Teva Pahrmaceutical
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy's Laboratories
Stada Arzneimittel AG

Market Size Split by Type
Recombinant Non-glycosylated Proteins
Recombinant Glycosylated Proteins
Recombinant Peptides
Market Size Split by Application
Oncology
Blood Disorders
Chronic Diseases
Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Other Diseases

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Follow-on Biologics market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Follow-on Biologics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Follow-on Biologics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Follow-on Biologics with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Follow-on Biologics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Follow-on Biologics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Follow-on Biologics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Follow-on Biologics Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Follow-on Biologics Market Size Growth Rate by Type
1.4.2 Recombinant Non-glycosylated Proteins
1.4.3 Recombinant Glycosylated Proteins
1.4.4 Recombinant Peptides
1.5 Market by Application
1.5.1 Global Follow-on Biologics Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Blood Disorders
1.5.4 Chronic Diseases
1.5.5 Autoimmune Diseases
1.5.6 Growth Hormone Deficiency
1.5.7 Infectious Diseases
1.5.8 Other Diseases
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Follow-on Biologics Market Size
2.1.1 Global Follow-on Biologics Revenue 2016-2025
2.1.2 Global Follow-on Biologics Sales 2016-2025
2.2 Follow-on Biologics Growth Rate by Regions
2.2.1 Global Follow-on Biologics Sales by Regions
2.2.2 Global Follow-on Biologics Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Follow-on Biologics Sales by Manufacturers
3.1.1 Follow-on Biologics Sales by Manufacturers
3.1.2 Follow-on Biologics Sales Market Share by Manufacturers
3.1.3 Global Follow-on Biologics Market Concentration Ratio (CR5 and HHI)
3.2 Follow-on Biologics Revenue by Manufacturers
3.2.1 Follow-on Biologics Revenue by Manufacturers (2016-2018)
3.2.2 Follow-on Biologics Revenue Share by Manufacturers (2016-2018)
3.3 Follow-on Biologics Price by Manufacturers
3.4 Follow-on Biologics Manufacturing Base Distribution, Product Types
3.4.1 Follow-on Biologics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Follow-on Biologics Product Category
3.4.3 Date of International Manufacturers Enter into Follow-on Biologics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Follow-on Biologics Sales by Type
4.2 Global Follow-on Biologics Revenue by Type
4.3 Follow-on Biologics Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Follow-on Biologics Breakdown Data by Application

6 North America
6.1 North America Follow-on Biologics by Countries
6.1.1 North America Follow-on Biologics Sales by Countries
6.1.2 North America Follow-on Biologics Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Follow-on Biologics by Type
6.3 North America Follow-on Biologics by Application
6.4 North America Follow-on Biologics by Company

7 Europe
7.1 Europe Follow-on Biologics by Countries
7.1.1 Europe Follow-on Biologics Sales by Countries
7.1.2 Europe Follow-on Biologics Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Follow-on Biologics by Type
7.3 Europe Follow-on Biologics by Application
7.4 Europe Follow-on Biologics by Company

8 Asia Pacific
8.1 Asia Pacific Follow-on Biologics by Countries
8.1.1 Asia Pacific Follow-on Biologics Sales by Countries
8.1.2 Asia Pacific Follow-on Biologics Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Follow-on Biologics by Type
8.3 Asia Pacific Follow-on Biologics by Application
8.4 Asia Pacific Follow-on Biologics by Company

9 Central & South America
9.1 Central & South America Follow-on Biologics by Countries
9.1.1 Central & South America Follow-on Biologics Sales by Countries
9.1.2 Central & South America Follow-on Biologics Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Follow-on Biologics by Type
9.3 Central & South America Follow-on Biologics by Application
9.4 Central & South America Follow-on Biologics by Company

10 Middle East and Africa
10.1 Middle East and Africa Follow-on Biologics by Countries
10.1.1 Middle East and Africa Follow-on Biologics Sales by Countries
10.1.2 Middle East and Africa Follow-on Biologics Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Follow-on Biologics by Type
10.3 Middle East and Africa Follow-on Biologics by Application
10.4 Middle East and Africa Follow-on Biologics by Company

11 Company Profiles
11.1 Sandoz
11.1.1 Sandoz Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Follow-on Biologics
11.1.4 Follow-on Biologics Product Description
11.1.5 Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Follow-on Biologics
11.2.4 Follow-on Biologics Product Description
11.2.5 Recent Development
11.3 Teva Pahrmaceutical
11.3.1 Teva Pahrmaceutical Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Follow-on Biologics
11.3.4 Follow-on Biologics Product Description
11.3.5 Recent Development
11.4 Celltrion
11.4.1 Celltrion Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Follow-on Biologics
11.4.4 Follow-on Biologics Product Description
11.4.5 Recent Development
11.5 Biocon
11.5.1 Biocon Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Follow-on Biologics
11.5.4 Follow-on Biologics Product Description
11.5.5 Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Follow-on Biologics
11.6.4 Follow-on Biologics Product Description
11.6.5 Recent Development
11.7 Samsung Biologics
11.7.1 Samsung Biologics Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Follow-on Biologics
11.7.4 Follow-on Biologics Product Description
11.7.5 Recent Development
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Follow-on Biologics
11.8.4 Follow-on Biologics Product Description
11.8.5 Recent Development
11.9 Dr. Reddy's Laboratories
11.9.1 Dr. Reddy's Laboratories Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Follow-on Biologics
11.9.4 Follow-on Biologics Product Description
11.9.5 Recent Development
11.10 Stada Arzneimittel AG
11.10.1 Stada Arzneimittel AG Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Follow-on Biologics
11.10.4 Follow-on Biologics Product Description
11.10.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Follow-on Biologics Raw Material
13.1.2 Follow-on Biologics Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Follow-on Biologics
Figure Global Follow-on Biologics Production (K Doses) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Follow-on Biologics Production Market Share by Types (Product Category) in 2017
Figure Recombinant Non-glycosylated Proteins Product Picture
Table Major Manufacturers of Recombinant Non-glycosylated Proteins
Figure Recombinant Glycosylated Proteins Product Picture
Table Major Manufacturers of Recombinant Glycosylated Proteins
Figure Recombinant Peptides Product Picture
Table Major Manufacturers of Recombinant Peptides
Table Global Follow-on Biologics Market Size Growth Rate by Application 2018-2025 (K Doses)
Figure Oncology
Figure Blood Disorders
Figure Chronic Diseases
Figure Autoimmune Diseases
Figure Growth Hormone Deficiency
Figure Infectious Diseases
Figure Other Diseases
Figure Follow-on Biologics Report Years Considered
Figure Global Follow-on Biologics Market Size 2016-2025 (Million US$)
Figure Global Follow-on Biologics Sales 2016-2025 (K Doses)
Table Global Follow-on Biologics Market Size by Regions 2016-2025 (K Doses) & (Million US$)
Table Global Follow-on Biologics Sales by Regions 2016-2025 (K Doses)
Table Global Follow-on Biologics Sales Market Share by Regions 2016-2025
Figure Global Follow-on Biologics Sales Market Share by Regions 2016-2025
Figure 2017 Global Follow-on Biologics Sales Market Share by Regions
Table Global Follow-on Biologics Revenue by Regions 2016-2025 (Million US$)
Table Global Follow-on Biologics Revenue Market Share by Regions 2016-2025
Figure Global Follow-on Biologics Revenue Market Share by Regions 2016-2025
Figure 2017 Global Follow-on Biologics Revenue Market Share by Regions
Table Global Follow-on Biologics Sales by Manufacturers (2016-2018) (K Doses)
Table Global Follow-on Biologics Sales Share by Manufacturers (2016-2018)
Figure Global Follow-on Biologics Sales Share by Manufacturers in 2017
Table Follow-on Biologics Revenue by Manufacturers (2016-2018) (Million US$)
Table Follow-on Biologics Revenue Share by Manufacturers (2016-2018)
Figure Follow-on Biologics Value Share by Manufacturers in 2017
Table Global Follow-on Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Follow-on Biologics Price (2016-2018) (USD/Dose)
Table Follow-on Biologics Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Follow-on Biologics Product Category
Table Date of International Manufacturers Enter into Follow-on Biologics Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Follow-on Biologics Sales by Type (2016-2025) (K Doses)
Table Global Follow-on Biologics Sales Share by Type (2016-2025)
Figure Global Follow-on Biologics Sales Market Share by Type (2016-2025)
Figure Global Follow-on Biologics Sales Market Share by Type in 2017
Table Global Follow-on Biologics Revenue by Type (2016-2025) (Million US$)
Table Global Follow-on Biologics Revenue Share by Type (2016-2025)
Figure Global Follow-on Biologics Revenue Market Share by Type (2016-2025)
Figure Global Follow-on Biologics Revenue Market Share by Type in 2017
Table Follow-on Biologics Price by Type 2013-2018 (USD/Dose)
Table Global Follow-on Biologics Sales by Application (2016-2025) (K Doses)
Table Global Follow-on Biologics Sales Share by Application (2016-2025)
Figure Global Sales Follow-on Biologics Market Share by Application (2016-2025)
Figure Global Sales Follow-on Biologics Market Share by Application (2016-2025)
Figure North America Follow-on Biologics Sales Growth Rate 2016-2025 (K Doses)
Figure North America Follow-on Biologics Revenue Growth Rate 2016-2025 (Million US$)
Table North America Follow-on Biologics Sales by Countries (2016-2025) (K Doses)
Table North America Follow-on Biologics Sales Market Share by Countries (2016-2025)
Figure 2017 North America Follow-on Biologics Sales Market Share by Countries
Table North America Follow-on Biologics Revenue by Countries (2016-2025) (Million US$)
Table North America Follow-on Biologics Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Follow-on Biologics Revenue Market Share by Countries
Figure United States Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure United States Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure Canada Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure Mexico Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Table North America Follow-on Biologics Sales by Type (2016-2025) (K Doses)
Table North America Follow-on Biologics Sales Market Share by Type (2016-2025)
Figure 2017 North America Follow-on Biologics Market Share by Type
Table North America Follow-on Biologics Sales by Application (2016-2025) (K Doses)
Table North America Follow-on Biologics Sales Market Share by Application (2016-2025)
Figure 2017 North America Follow-on Biologics Market Share by Application
Table North America Follow-on Biologics Sales by Company (2016-2018) (K Doses)
Table North America Follow-on Biologics Sales Market Share by Company (2016-2018)
Figure North America Follow-on Biologics Sales Market Share by Company in 2017
Figure Europe Follow-on Biologics Sales Growth Rate 2016-2025 (K Doses)
Figure Europe Follow-on Biologics Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Follow-on Biologics Sales by Countries (2016-2025) (K Doses)
Table Europe Follow-on Biologics Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Follow-on Biologics Sales Market Share by Countries
Table Europe Follow-on Biologics Revenue by Countries (2016-2025) (Million US$)
Table Europe Follow-on Biologics Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Follow-on Biologics Revenue Market Share by Countries
Figure Germany Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure Germany Follow-on Biologics Revenue Growth Rate (2016-2025) (K Doses)
Figure France Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure France Follow-on Biologics Revenue Growth Rate (2016-2025) (K Doses)
Figure UK Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure UK Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure Italy Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure Russia Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Follow-on Biologics Sales by Type (2016-2025) (K Doses)
Table Europe Follow-on Biologics Sales Market Share by Type (2016-2025)
Figure 2017 Europe Follow-on Biologics Market Share by Type
Table Europe Follow-on Biologics Sales by Application (2016-2025) (K Doses)
Table Europe Follow-on Biologics Sales Market Share by Application (2016-2025)
Figure 2017 Europe Follow-on Biologics Market Share by Application
Table Europe Follow-on Biologics Sales by Company (2016-2018) (K Doses)
Table Europe Follow-on Biologics Sales Market Share by Company (2016-2018)
Figure Europe Follow-on Biologics Sales Market Share by Company in 2017
Figure Asia Pacific Follow-on Biologics Sales Growth Rate 2016-2025 (K Doses)
Figure Asia Pacific Follow-on Biologics Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Follow-on Biologics Sales by Countries (2016-2025) (K Doses)
Table Asia Pacific Follow-on Biologics Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Follow-on Biologics Sales Market Share by Countries
Table Asia Pacific Follow-on Biologics Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Follow-on Biologics Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Follow-on Biologics Revenue Market Share by Countries
Figure China Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure China Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure Japan Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure Korea Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Figure India Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure India Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure Australia Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure Indonesia Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure Malaysia Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure Philippines Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure Thailand Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure Vietnam Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure Singapore Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Follow-on Biologics Sales by Type (2016-2025) (K Doses)
Table Asia Pacific Follow-on Biologics Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Follow-on Biologics Market Share by Type
Table Asia Pacific Follow-on Biologics Sales by Application (2016-2025) (K Doses)
Table Asia Pacific Follow-on Biologics Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Follow-on Biologics Market Share by Application
Table Asia Pacific Follow-on Biologics Sales by Company (2016-2018) (K Doses)
Table Asia Pacific Follow-on Biologics Sales Market Share by Company (2016-2018)
Figure Asia Pacific Follow-on Biologics Sales Market Share by Company in 2017
Figure Central & South America Follow-on Biologics Sales Growth Rate 2016-2025 (K Doses)
Figure Central & South America Follow-on Biologics Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Follow-on Biologics Sales by Countries (2016-2025) (K Doses)
Table Central & South America Follow-on Biologics Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Follow-on Biologics Sales Market Share by Countries
Table Central & South America Follow-on Biologics Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Follow-on Biologics Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Follow-on Biologics Revenue Market Share by Countries
Figure Brazil Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure Brazil Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure Argentina Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Follow-on Biologics Sales by Type (2016-2025) (K Doses)
Table Central & South America Follow-on Biologics Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Follow-on Biologics Market Share by Type
Table Central & South America Follow-on Biologics Sales by Application (2016-2025) (K Doses)
Table Central & South America Follow-on Biologics Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Follow-on Biologics Market Share by Application
Table Central & South America Follow-on Biologics Sales by Company (2016-2018) (K Doses)
Table Central & South America Follow-on Biologics Sales Market Share by Company (2016-2018)
Figure Central & South America Follow-on Biologics Sales Market Share by Company in 2017
Figure Middle East and Africa Follow-on Biologics Sales Growth Rate 2016-2025 (K Doses)
Figure Middle East and Africa Follow-on Biologics Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Follow-on Biologics Sales by Countries (2016-2025) (K Doses)
Table Middle East and Africa Follow-on Biologics Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Follow-on Biologics Sales Market Share by Countries
Table Middle East and Africa Follow-on Biologics Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Follow-on Biologics Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Follow-on Biologics Revenue Market Share by Countries
Figure GCC Countries Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure GCC Countries Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure Turkey Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure Egypt Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Follow-on Biologics Sales Growth Rate (2016-2025) (K Doses)
Figure South Africa Follow-on Biologics Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Follow-on Biologics Sales by Type (2016-2025) (K Doses)
Table Middle East and Africa Follow-on Biologics Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Follow-on Biologics Market Share by Type
Table Middle East and Africa Follow-on Biologics Sales by Application (2016-2025) (K Doses)
Table Middle East and Africa Follow-on Biologics Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Follow-on Biologics Market Share by Application
Table Middle East and Africa Follow-on Biologics Sales by Company (2016-2018) (K Doses)
Table Middle East and Africa Follow-on Biologics Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Follow-on Biologics Sales Market Share by Company in 2017
Table Sandoz Company Details
Table Sandoz Follow-on Biologics Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Sandoz Recent Development
Table Pfizer Company Details
Table Pfizer Follow-on Biologics Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Teva Pahrmaceutical Company Details
Table Teva Pahrmaceutical Follow-on Biologics Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Teva Pahrmaceutical Recent Development
Table Celltrion Company Details
Table Celltrion Follow-on Biologics Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Celltrion Recent Development
Table Biocon Company Details
Table Biocon Follow-on Biologics Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Biocon Recent Development
Table Amgen Company Details
Table Amgen Follow-on Biologics Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Amgen Recent Development
Table Samsung Biologics Company Details
Table Samsung Biologics Follow-on Biologics Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Samsung Biologics Recent Development
Table Mylan Company Details
Table Mylan Follow-on Biologics Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Mylan Recent Development
Table Dr. Reddy's Laboratories Company Details
Table Dr. Reddy's Laboratories Follow-on Biologics Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Dr. Reddy's Laboratories Recent Development
Table Stada Arzneimittel AG Company Details
Table Stada Arzneimittel AG Follow-on Biologics Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Stada Arzneimittel AG Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Follow-on Biologics Value Chain
Table Typical Suppliers of Key Follow-on Biologics Raw Material
Table Follow-on Biologics Customers List
Table Follow-on Biologics Sales Channels
Table Follow-on Biologics Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *